S&P 500 7,637.76 +1.14%
Nasdaq 26,418.30 +1.69%
S&P/TSX 35,874.26 +1.08%
Apple 337.00 +1.38%
Nvidia 219.34 +2.54%
Microsoft 497.75 +1.52%
Shopify 180.01 −0.97%
Royal Bank 284.93 +0.66%
CAD/USD 0.7155 +0.09%
CLOSED · 00:05 ET
Market ClerkRecap
Fri Sep 18 · markets closed3 signals on Sep 17300 insider buys this week · $205.1MCIRO short report next: Sep 29The week ahead
ET
INSIDER · AIM · AIM ImmunoTech Inc. · CEO & PRESIDENT

Equels Thomas K

Every open-market transaction filed under this name, Sep 14 to Sep 16.

Filings
3
3 buys · 0 sells
Bought
$8K
open market, at cost
Sold
includes scheduled sales
Buys since
+0.2%
avg move from buy price, 3 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 16AIMAIM ImmunoTech Inc.CEO & PresidentBuy11,000$0.21$2K+3.3%
Sep 15AIMAIM ImmunoTech Inc.CEO & PresidentBuy22,000$0.22$5K−1.8%
Sep 14AIMAIM ImmunoTech Inc.CEO & PresidentBuy5,900$0.22$1K−0.9%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.